Literature DB >> 22028438

Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.

Norma I Rallón1, Judit Morello, Pablo Labarga, José M Benito, Sonia Rodríguez-Nóvoa, Eugenia Vispo, Pablo Barreiro, M Ángeles Castro, Koldo Aguirrebengoa, Juan A Pineda, P Miralles, M Jesús Tellez, Joaquín Portu, Celia Miralles, Antonio Ocampo, Vincent Soriano.   

Abstract

The role of rs1127354/rs7270101 alleles at the inosine triphosphatase (ITPA) gene on ribavirin-induced anemia was assessed in 74 patients with hepatitis C virus and human immunodeficiency virus coinfection. Anemia developed in 80% of patients with normal ITPA activity compared with 33% of those with reduced ITPA activity. In contrast, ITPA variants did not influence sustained virological response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22028438     DOI: 10.1093/cid/cir665

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

Review 1.  Pharmacogenomics of antimicrobial agents.

Authors:  Ar Kar Aung; David W Haas; Todd Hulgan; Elizabeth J Phillips
Journal:  Pharmacogenomics       Date:  2014       Impact factor: 2.533

2.  Association of ITPA gene polymorphisms and the risk of ribavirin-induced anemia in HIV/hepatitis C virus (HCV)-coinfected patients receiving HCV combination therapy.

Authors:  Pere Domingo; Josep M Guardiola; Juliana Salazar; Ferran Torres; M Gracia Mateo; Cristina Pacho; M Del Mar Gutierrez; Karuna Lamarca; Angels Fontanet; Jordi Martin; Jessica Muñoz; Francesc Vidal; Montserrat Baiget
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

3.  Is Ribavirin Teratogenic in Humans? No Evidence So Far.

Authors:  Vicente Soriano; Pablo Barreiro
Journal:  Drug Saf       Date:  2017-12       Impact factor: 5.606

4.  Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysis.

Authors:  Daniel Pineda-Tenor; Mónica García-Álvarez; María A Jiménez-Sousa; Sonia Vázquez-Morón; Salvador Resino
Journal:  J Transl Med       Date:  2015-10-06       Impact factor: 5.531

5.  Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.

Authors:  Francesc Vidal; Miguel López-Dupla; Montserrat Laguno; Sergi Veloso; Josep Mallolas; Javier Murillas; Carmen Cifuentes; Lluis Gallart; Teresa Auguet; Gloria Sampériz; Antoni Payeras; Pilar Hernandez; Mireia Arnedo; Josep Ma Gatell; Cristóbal Richart
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.